Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ELI LILLY & CO (LLY)

  • Business News
  • May 29, 2026, 16:44 UTC
  • 4
  • 1 comments

Clinical trial NCT06952530 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 487 participants

Market reaction Comment Full text

EDWARDS LIFESCIENCES CORP (EW)

  • Business News
  • May 29, 2026, 16:44 UTC
  • 4
  • 1 comments

Clinical trial NCT04097145: enrollment: not set → 1270 participants.

Market reaction Comment Full text

SANOFI (SNYNF)

  • Business News
  • May 29, 2026, 16:44 UTC
  • 4
  • 1 comments

Clinical trial NCT01915212: enrollment: not set → 69 participants.

Market reaction Comment Full text

BEONE MEDICINES LTD. (IGNE)

  • Business News
  • May 29, 2026, 16:44 UTC
  • 4
  • 1 comments

Clinical trial NCT07043400: enrollment: not set → 351 participants.

Market reaction Comment Full text

UNITED THERAPEUTICS CORP (UTHR)

  • Business News
  • May 29, 2026, 16:44 UTC
  • 4
  • 1 comments

Clinical trial NCT07604701: enrollment: not set → 226 participants.

Market reaction Comment Full text

GSK PLC (GSK)

  • Business News
  • May 29, 2026, 16:44 UTC
  • 4
  • 1 comments

Clinical trial NCT05819892: enrollment: not set → 21 participants.

Market reaction Comment Full text

MOLECULAR PARTNERS AG (MLLCF)

  • Business News
  • May 29, 2026, 16:44 UTC
  • 4
  • 1 comments

Clinical trial NCT01905826: enrollment: not set → 600 participants.

Market reaction Comment Full text

DOGWOOD THERAPEUTICS, INC. (DWTX)

  • Business News
  • May 29, 2026, 16:44 UTC
  • 4
  • 1 comments

Clinical trial NCT06848348: enrollment: not set → 240 participants.

Market reaction Comment Full text

UNITED THERAPEUTICS CORP (UTHR)

  • Business News
  • May 29, 2026, 16:44 UTC
  • 4
  • 1 comments

Clinical trial NCT05987956: enrollment: not set → 600 participants.

Market reaction Comment Full text

BOSTON SCIENTIFIC CORPORATION

  • Business News
  • May 29, 2026, 16:44 UTC
  • 2
  • 1 comments

Clinical trial NCT05822219 updates: 1. completion date: 2027-03-30 → 2027-12-31 2. primary completion date: 2026-03-31 → 2026-04-01 3. enrollment: not set → 60 participants

Market reaction Comment Full text
  • Previous
  • 876
  • 877
  • 878
  • 879
  • 880
  • Next

Search

News categories

  • Technical Exchange News(13176)
  • Event(6229)
  • SEC News(332089)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(184970)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin